Long-term operation rate and related prognostic factors in patients with Crohn's Disease treated by infliximab maintenance treatment

被引:0
|
作者
Tanaka, H. [1 ]
Miyakawa, M. [1 ]
Sakemi, R. [1 ]
Nasuno, M. [1 ]
Motoya, S. [1 ]
Imamura, A. [1 ]
机构
[1] Sapporo Kosei Gen Hosp, IBD Ctr, Sapporo, Hokkaido, Japan
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P571
引用
收藏
页码:S365 / S366
页数:2
相关论文
共 50 条
  • [1] Long-term operation rate and related prognostic factors in patients with Crohn's disease treated by infliximab maintenance treatment
    Tanaka, Hiroki
    Miyakawa, Maki
    Nasuno, Masanao
    Motoya, Satoshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 105 - 105
  • [2] Long-term Operation Rates and Related Prognostic Factors in Patients with Crohn's Disease Treated by Infliximab: A Japanese Single-center Cohort Study
    Nasuno, Masanao
    Miyakawa, Maki
    Tanaka, Hiroki
    Motoya, Satoshi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S300 - S300
  • [3] Long-term outcome and related prognostic factors of infliximab maintenance treatment for Japanese patients with Crohn's disease: A Japanese single-center study
    Miyakawa, Maki
    Tanaka, Hiroki
    Sugiyama, Kohei
    Nasuno, Masanao
    Motoya, Satoshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 110 - 110
  • [4] Long-term outcome of Crohn's disease patients treated with infliximab
    Chen, B. L.
    Lv, S. C.
    Feng, T.
    Li, M. Y.
    Rao, P. S.
    Zeng, Z. R.
    Hu, P. J.
    Chen, M. H.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S245 - S245
  • [5] Factors influencing long-term outcome of infliximab treatment in Crohn's disease
    Sachdev, R
    Banks, PA
    Wolf, JL
    Strate, LL
    Friedman, S
    GASTROENTEROLOGY, 2003, 124 (04) : A527 - A527
  • [6] The Course of Infliximab Discontinuation After Long-Term Maintenance Treatment in Crohn's Disease
    Armuzzi, Alessandro
    Rizzi, Marina
    Monterubbianesi, Rita
    Marzo, Manuela
    Cicala, Michele
    Guidi, Luisa
    Prantera, Cosimo
    Kohn, Anna
    GASTROENTEROLOGY, 2010, 138 (05) : S687 - S687
  • [7] Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience
    Billiet, T.
    Cleynen, I.
    Ballet, V.
    Ferrante, M.
    Van Assche, G.
    Gils, A.
    Vermeire, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (07) : 673 - 683
  • [8] Surgery rate in patients with Crohn's disease with regard to long-term clinical outcome of infliximab treatment
    Pedersen, Natalia
    Duricova, Dana
    Lenicek, Martin
    Elkjaer, Margarita
    Lukas, Milan
    Munkhohn, Pia S.
    GASTROENTEROLOGY, 2008, 134 (04) : A502 - A502
  • [9] Long-Term Durability of Crohn’s Disease Treatment with Infliximab
    Stephen J. Rudolph
    David I. Weinberg
    Robert P. McCabe
    Digestive Diseases and Sciences, 2008, 53 : 1033 - 1041
  • [10] Infliximab in Crohn's disease: early and long-term treatment
    Armuzzi, A.
    De Pascalis, B.
    Fedeli, P.
    De Vincentis, F.
    Gasbarrini, A.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S271 - S279